The innovations from oncology pharmaceutical companies over recent decades have dramatically changed cancer treatment. Furthermore, new therapies developed by companies have prolonged patients' lives and improved their quality of life. Read further to learn more about the influence of cancer ...

Read More

Diabetes already causes an epidemic worldwide, with 578 million expected by 2030 and 700 million in 2045. In the backdrop of the ever-growing prevalence of diabetes, pharma third-party manufacturing companies face various challenges like high R&D costs, regulatory hurdles, and ...

Read More

In the rapidly growing pharmaceutical industry, companies always seek the best CDMO services that help them improve and streamline their drug creation process. These services offer support in research, expertise, and infrastructure, thus reducing delays that could otherwise affect the ...

Read More

According to recent statistics, there's a vast and increasing amount of money being put into research and development for cancer drugs, almost over $50 billion each year. Due to this more and more cancer treatments are being developed in comparison ...

Read More

In the rapidly changing field of oncology, creating successful cancer therapies is only the start. Transporting these life-saving medications from the laboratory to the market necessitates a smooth progression from development to production. CDMOs play a vital role by providing ...

Read More

In the field of medication , the process of a pill traveling from creation to ingestion is a complex and intriguing voyage. Navigating oncology medication adds an extra layer of complexity to the journey, as these drugs are essential in ...

Read More

Diabetes is a significant health problem worldwide, with India experiencing a notable impact. With the growth in diabetes cases, the need for efficient treatment is also rising. Indian pharmaceutical firms, including companies focused on oncology, like Pinnacle Life Science, play ...

Read More

India is a critical player in the pharmaceutical sector, significantly contributing to producing essential medications such as Apixaban, a blood thinner used to prevent blood clots in patients with atrial fibrillation, deep vein thrombosis, and pulmonary embolism. Indian manufacturers must ...

Read More